Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Likely successor says the Pope may be nearing his final days

Likely successor says the Pope may be nearing his final days

Study on RNAi technology targeting neurodegenerative diseases

Study on RNAi technology targeting neurodegenerative diseases

New screening tool prevents wrong patients from receiving Parkinson's surgery

New screening tool prevents wrong patients from receiving Parkinson's surgery

Approval of Cymbalta for treatment of major depressive disorder

Approval of Cymbalta for treatment of major depressive disorder

Clinical trial established that two drugs, levodopa and pramipexole, are both viable initial treatments for Parkinson's disease

Clinical trial established that two drugs, levodopa and pramipexole, are both viable initial treatments for Parkinson's disease

Scientists have produced a prion protein that can trigger the development of a neurological disorder similar to "mad cow" disease

Scientists have produced a prion protein that can trigger the development of a neurological disorder similar to "mad cow" disease

Researchers have shown that an experimental vaccine can reduce the amount of neurodegeneration in a mouse model for Parkinson's disease

Researchers have shown that an experimental vaccine can reduce the amount of neurodegeneration in a mouse model for Parkinson's disease

75 percent of Americans support call for more stem cell research

75 percent of Americans support call for more stem cell research

New plan of action aims to reduce prescription drug costs by more than 50 percent

New plan of action aims to reduce prescription drug costs by more than 50 percent

Drug used to treat schizophrenia and other psychotic disorders appears effective at treating Alzheimer’s disease

Drug used to treat schizophrenia and other psychotic disorders appears effective at treating Alzheimer’s disease

Effects of Huntington's disease mutation more complex than originally thought

Effects of Huntington's disease mutation more complex than originally thought

Clinical study compares treatments in early Parkinson's disease

Clinical study compares treatments in early Parkinson's disease

Levodopa and pramipexole appear to be reasonable options as initial therapy for Parkinson disease

Levodopa and pramipexole appear to be reasonable options as initial therapy for Parkinson disease

California church coalition lends support to Proposition 71 for stem cell research

California church coalition lends support to Proposition 71 for stem cell research

World’s leading experts to attend International Human Embryonic Stem Cell Symposium

World’s leading experts to attend International Human Embryonic Stem Cell Symposium

Possibility of generating nerve cells from an individual’s own skin cells

Possibility of generating nerve cells from an individual’s own skin cells

Researchers shed new light on the function of huntingtin, the protein whose mutation underlies Huntington’s disease

Researchers shed new light on the function of huntingtin, the protein whose mutation underlies Huntington’s disease

Drop in systolic blood pressure may indicate imminent likelihood of Alzheimer’s disease or dementia

Drop in systolic blood pressure may indicate imminent likelihood of Alzheimer’s disease or dementia

Positron emission tomography offers a better way to observe the damage that strokes and neurodegenerative diseases wreak on brain cells

Positron emission tomography offers a better way to observe the damage that strokes and neurodegenerative diseases wreak on brain cells

By altering a single gene you could live longer and be thinner

By altering a single gene you could live longer and be thinner

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.